TY - JOUR T1 - A predictive model of a growing fetus JF - medRxiv DO - 10.1101/2022.12.22.22283844 SP - 2022.12.22.22283844 AU - Chandrani Kumari AU - Gautam I Menon AU - Leelavati Narlikar AU - Uma Ram AU - Rahul Siddharthan Y1 - 2022/01/01 UR - http://medrxiv.org/content/early/2022/12/22/2022.12.22.22283844.abstract N2 - Fetal growth is monitored periodically during pregnancy via ultrasound measurements of fetal dimensions such as femur length (FL), head circumference (HC), abdominal circumference (AC), and biparietal diameter (BPD). Multiple growth standards have been published for each of these, which are clinically used to place a fetus on a “growth chart”. These consist of percentile tables varying by weeks of gestation, computed from cohorts of “low-risk” women with healthy lifestyles, living conditions, and clinical parameters. Such charts are prescriptive of ideal growth, but not necessarily descriptive of diverse real-world populations where they may be used. Moreover, they are constructed by pooling all fetal measurements across the cohort, not based on a growth model, and therefore not necessarily predictive of growth of an individual fetus.We show that the Gompertz model, a standard model for constrained growth, with just three intuitive parameters, convincingly fits the growth of fetal ultrasound biometries. Two of these parameters—t0 (the inflection time) and c (the rate of decrease of growth rate)—can be treated as universal to all fetuses, while the third parameter A can be modeled as an overall scale parameter specific to each fetus, which captures the individual variation in growth. On our cohort of 817 pregnant women (“Seethapathy cohort”), we show that not only can the value of A for each fetus be inferred from ultrasound data available by the second or the third trimester, but the weight of the baby at delivery can also be predicted with remarkable accuracy using these inferred Gompertz parameters. A model trained on the Seethapathy cohort performs well in estimating the birth weight in an independent validation cohort of 365 women, demonstrating the predictive power of the model. Moreover, we find that deviation from Gompertz-like growth is linked to neonatal complications. Finally, we show that the Gompertz growth curve is a close fit to the standards from WHO, NICHD and INTERGROWTH, with the optimal t0 and c close to that in the Seethapathy cohort. We propose that the Gompertz formula be a basis for future growth standards, with almost all variation described by a single scale parameter A, which can serve either as a descriptor of mean or variance in population, or as a descriptor for growth of an individual fetus. Indeed, the formula is descriptive of typical growth, predictive of future growth, and may be used in prescriptive standards.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe acknowledge funding from BIRAC grant bt/ki-data0404/06/18 (LN, GM, UR, RS), and the IMSc Centre for Disease Modelling (ICDM) funded via an apex project at IMSc by the Department of Atomic Energy, Government of India (CK, RS)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Independent Ethics Committee of the Fetal Care Research Foundation, Chennai, gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available online at https://github.com/chandranikumari/FetusGrowthModel ER -